Replimune Group Inc (NASDAQ: REPL) stock jumped 0.78% on Friday to $10.40 against a previous-day closing price of $10.32. With 1.53 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.66 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $11.29 whereas the lowest price it dropped to was $10.25. The 52-week range on REPL shows that it touched its highest point at $29.52 and its lowest point at $10.26 during that stretch. It currently has a 1-year price target of $48.89. Beta for the stock currently stands at 1.47.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of REPL was down-trending over the past week, with a drop of -6.39%, but this was down by -28.72% over a month. Three-month performance dropped to -47.21% while six-month performance fell -46.88%. The stock lost -45.89% in the past year, while it has lost -61.76% so far this year. A look at the trailing 12-month EPS for REPL yields -3.20 with Next year EPS estimates of -3.70. For the next quarter, that number is -0.88. This implies an EPS growth rate of -16.64% for this year and -6.06% for next year.
Float and Shares Shorts:
At present, 56.68 million REPL shares are outstanding with a float of 43.38 million shares on hand for trading. On Oct 30, 2023, short shares totaled 8.72 million, which was 14.77% higher than short shares on Sep 28, 2023. In addition to Mr. Philip Astley-Sparke F.S.A. as the firm’s CEO & Director, Dr. Sushil Patel Ph.D. serves as its Chief Strategy Officer.
Institutional Ownership:
Through their ownership of 94.99% of REPL’s outstanding shares, institutional investors have majority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for REPL since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With REPL analysts setting a high price target of $70.00 and a low target of $32.00, the average target price over the next 12 months is $48.89. Based on these targets, REPL could surge 573.08% to reach the target high and rise by 207.69% to reach the target low. Reaching the average price target will result in a growth of 370.1% from current levels.
Summary of Insider Activity:
Insiders traded REPL stock several times over the past three months with 5 Buys and 3 Sells. In these transactions, 107,588 shares were bought while 24,258 shares were sold. The number of buy transactions has increased to 18 while that of sell transactions has risen to 19 over the past year. The total number of shares bought during that period was 603,588 while 161,624 shares were sold.
